01/01/1996 - "T-440 may be an effective agent to treat atopic diseases associated with eosinophilic inflammation, e.g. "
10/01/1996 - "We conclude that T-440 suppressed cytokine production by peripheral T lymphocytes via the protein kinase A pathway and may be an effective modality to treat atopic diseases associated with eosinophilic inflammation."
01/01/1996 - "A novel phosphodiesterase inhibitor, T-440: possible management of eosinophilic inflammation by down-regulation of interleukin-5 production."
|1.||Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)
|2.||Interleukin-5 (Interleukin 5)